Additionally, oncogenes such as MYC and N-MYC disrupt circadian rhythms by inducing REV-ERBα, which reduces BMAL1 levels and rhythmic activity, thereby impacting tumour growth and metabolism.83 The gene discussed is BMAL1; the disease is neoplasm.